Cost-effectiveness of Oral Protease Inhibitors Co-administration versus Pegylated Interferon-Α2b and Ribavirin Only for the Patients with Hepatitis C Genotype 1 in Kazakhstan Health Care Settings

BACKGROUND: The triple therapy including peginterferon, ribavirin and protease inhibitors was more effective compared to the combination of only peginterferon and ribavirin. This study aimed to assess the cost-effectiveness of triple treatment in either treatment-naïve and treatment-experienced pati...

Descripción completa

Detalles Bibliográficos
Autores principales: ALMADIYEVA, Alima, IBRAYEV, Serik, TURGAMBAYEVA, Assiya, KOSTYUK, Alexandr, KHISMETOVA, Zayituna, AKHMETOVA, Zhanar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379623/
https://www.ncbi.nlm.nih.gov/pubmed/30788299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379623/
https://www.ncbi.nlm.nih.gov/pubmed/30788299

Ejemplares similares